On Dec. 27, 2021, Moderna announced a revised supply agreement with the government of South Korea for 20 million doses of Moderna’s COVID-19 vaccine or an updated booster vaccine candidate, if authorized.

Under the terms of the agreement, Moderna expected to deliver 15 million doses in the third quarter of 2022 and 5 million doses in the fourth quarter of 2022.